Hepatitis C prevalence and risk behavior of injecting drug users in Sydney: A continuing concern

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 32, Issue 4, 2001, Pages 823-834

  Habib, Shah E ^a   Lovejoy, Frances H ^a   Aspin, Clive ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; DRUG ABUSE; FEMALE; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL ASPECT; SEXUAL BEHAVIOR; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; NEW SOUTH WALES; PREVALENCE; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0035751188     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barnard MA. Needle sharing in context: patterns of sharing among men and women injectors and HIV risk. Addiction 1993; 88: 805-12.
2. Bell J, Battey RG, Farrell GC, Crewe EB, Cunningham, AL, Karen B. Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153: 274-6.
3. Bodsworth NJ, Cunningham P, Kaldor J, Donovan B. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behavior. Genitourin Med 1996; 72: 118-2.
4. Carruthers S, Loxley W, Phillips M, Bevan J. The Australian Study of HIV and Injecting Drug Use. Part II: Predicting exposure to hepatitis C and hepatitis B. Drug Alcohol Rev 1997; 16: 215-20.
5. Cregan J. Hepatitis C, prisons, and public health. Aust NZ J Public Health 1998; 22: 5-7.
6. Crofts N, Hopper J, Bowden S, Breschkin A, Milner R, Locarnini S. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237-41.
7. Crofts N, Aitken CK. Incidence of and risk behaviors for blood-borne viruses in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust 1997; 167: 17-20.
8. Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Com Health 1997; 51: 692-7.
9. Crofts N, Thompson S, Kaldor J. Epidemiology of the hepatitis C virus. Communicable Diseases Intelligence, (Technical Report Series No. 3), Commonwealth Department of Health and Aged Care, Australia, 1999.
10. Darke S, Hall W, Carless J. Drug use, injecting practices and sexual behavior of opioid users in Sydney, Australia. Br J Addict 1990; 85: 1603-9.
11. Dienstag JL. Sexual and perinatal transmission of hepatitis C. Hepatology 1997; 26 (suppl 3): 66S-70S.
12. Gupta L, Puech MC, Ward JE. Service expectations, self-reported educational and resource needs of general practitioners in managing patients with hepatitis C. Drug Alcohol Rev 2000; 19: 65-71.
13. Griffiths P, Gossop M, Powis B, Strang J. Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction 1994; 89: 301-9.
14. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley, 1989.
15. Hulse GK. Australia's public health response to HIV and HCV: a role for 'affected' communities. Drug Alcohol Rev 1997; 16: 171-6.
16. Lenton S, Tan-Quigley A. The Fitpack Study: A Survey of 'Hidden' Drug Injectors with Minimal Drug Treatment Experience. Perth, Western Australia: National Centre for Research into the Prevention of Drug Abuse, Curtain University of Technology, 1997.
17. Loxley W, Bevan J, Carruthers S. Age and injecting drug use revisited: the Australian study of the HIV and injecting drug use. AIDS Care 1997a; 9: 667-70.
18. Loxley WM, Philips M, Carruthers S, Bevan JS. The Australian study of HIV and injecting drug use. Part I: Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities. Drug Alcohol Rev 1997b; 16: 207-14.
19. MacDonald M, Wodak A, Ali R, et al. HIV prevalence and risk behavior in needle exchange attenders - a national study. Med J Aust 1997; 166: 237-40.
20. MacDonald MA, Wodak AD, Dolan KA, et al. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Med J Aust 2000; 172: 57-61.
21. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Hepatitis C and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2000, Sydney, The University of New South Wales, NCHECR, 2000: 59-70.
22. National Health and Medical Research Council. A Strategy for the Detection and Management of Hepatitis C in Australia. Canberra, Commonwealth of Australia, NHMRC, 1997: 1-20.
23. Orr N, Leeder S. The public health challenge of hepatitis C. Aust NZ J Public Health 1998; 22: 191-5.
24. Rockwell R, Des Jarlais DC, Friedman SR, Perlis TE, Paone D. Geographical proximity, policy and utilization of syringe exchange programmes. AIDS Care 1999; 11: 437-42.
25. Sharon JH, Taylor A, Goldberg DJ, Gruer L. Factors associated with injecting risk behavior among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses. Addiction 2000; 95: 931-40.
26. Standing Committee on Social Issues. Hepatitis C: The Neglected Epidemic, Inquiry into Hepatitis C in New South Wales. Legislative Council, Parliament of New South Wales, Sydney. SCSI 1998: p 37.
27. Thomas DL, Cannon RO, Shapiro CN, Hook EW, Alter MJ, Quinn TC. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994; 169: 990-5.
28. Van Ameijden EJC, Van Den Hoek A, Coutinho RA. Injecting risk behavior among drug users in Amsterdam, 1986-1992, and its relationship to AIDS prevention programs. Am J Public Health 1994; 84: 275-81.
29. Van Beek I, Buckley R, Stewart M, MacDonald M, Kaldor J. Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourin Med 1994; 70: 321-4.
30. Van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. Br Med J 1998; 317: 433-7.
31. Van De Ven P, Kippax S, Crawford J, Rodden P. Injecting drug use and knowledge and self-report of hepatitis C among Australian gay and homosexually active men. Drug Alcohol Rev 1999; 18: 271-7.
32. Watson R, Crofts N, Mitchell C, Aitken C, Hocking J, Tompson S. Risk factors for hepatitis C transmission in the Victorian population: a telephone survey. Aust NZ J Public Health 1999; 23: 622-6.
33. Watson KJR. Preventing hepatitis C virus transmission in Australians who inject drugs. Med J Aust 2000; 172: 55-6.
34. Wodak A, Crofts N. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users. Aust J Public Health 1994; 18: 239-41.
35. Wodak A. Injecting nation: achieving control of hepatitis C in Australia (The 1996 James Rankin Oration). Drug Alcohol Rev 1997a; 16: 275-84.
36. Wodak A. Hepatitis C: waiting for the Grim Reaper (Editorial). Med J Aust 1997b; 166: 284-5.